Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Ipsen Completes Acquisition of Albireo
Thursday, March 02, 2023Ipsen announced it has completed the acquisition of Albireo Pharma The acquisition enriches Ipsens Rare Disease portfolio with promising therapeutics for paediatric and adult rare cholestaticliver diseases innovative pipeline potential as well as sci...
Intellia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application
Thursday, March 02, 2023Intellia Therapeutics announced that the US Food and Drug Administration FDA has cleared the companys Investigational New Drug IND application for NTLA for the treatment of hereditary angioedema HAE enabling the company to include the United States i...
Chugai and Biofourmis Enter into New Partnership
Thursday, March 02, 2023Chugai Pharmaceutical and Biofourmis announced that they have entered into a new partnership agreement for the continued development and realworld use of digital solutions to objectively measure pain in patients with endometriosis Endometriosis affec...
Bionxt Signs Agreement for Study of Transdermal Rotigotine Patch
Wednesday, March 01, 2023BioNxt Solutions announced agreement to carry out its comparative drug absorption study for the Companys transdermal TDS Rotigotine patch for the treatment of Parkinsons disease The comparative study is designed as a randomised crossover twoperiod si...
BioLife Solutions Launches Ultraguard™ -70°C Phase Change Material (PCM)
Wednesday, March 01, 2023BioLife Solutions announced the launch of Ultraguard the first ever nontoxic nonhazardous and nonflammable C phase change material PCM for ultralow temperature ULT protection The Ultraguard PCM form factor is an ergonomicfriendly plastic bottle or br...
Oragenics Enters into an Exclusive Global Licence Agreement with Inspirevax
Wednesday, March 01, 2023Oragenics announced that the Company has entered into an exclusive global licence agreement with Inspirevax for its novel intranasal mucosal adjuvant BDX for the development of NTCoV Oragenics lead intranasal COVID vaccine candidate Under the exclusi...
Nubeqa™ (darolutamide) Receives EU approval
Wednesday, March 01, 2023The European Commission has granted marketing authorisation in the European Union EU for Nubeqa darolutamide an oral androgen receptor inhibitor ARi plus androgen deprivation therapy ADT in combination with docetaxel for the treatment of patients wit...
U.S. FDA Accepts Bristol Myers Squibb’s Supplemental Biologics Licence Application
Tuesday, February 28, 2023Bristol Myers Squibb announced that the US Food and Drug Administration FDA has accepted the supplemental Biologics Licence Application sBLA and the European Medicines Agency EMA has validated the Type II Variation Marketing Authorisation Application...
Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omavaloxolone)
Tuesday, February 28, 2023Reata Pharmaceuticals announced that the US Food and Drug Administration FDA has approved SKYCLARYS omaveloxolone for the treatment of Friedreichs ataxia in adults and adolescents aged years and older The approval of SKYCLARYS is the first therapy s...
Regeneron and Sanofi Announce U.S. FDA Approval of Kevzara® (sarilumab)
Tuesday, February 28, 2023Regeneron Pharmaceuticals and Sanofi announced that the US Food and Drug Administration FDA has approved Kevzara sarilumab for the treatment of polymyalgia rheumatica PMR an inflammatory rheumatic disease in adult patients consisting of inadequate re...
